| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 Molecular Virology Section, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland; 2 Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Shogoin Kawahara-cho, Sakyo-ku, Kyoto, Japan; 3 Institut National de la Santé et de la Recherche Médicale, U624, Stress Cellulaire, IFR 137-Institut de Cancerologie et Immunologie de Marseille, Universite de la Mediterranee, Marseille, France; 4 Laboratoire de Virologie Moleculaire, Institut de Genetique Humaine, Centre National de la Recherche Scientifique, UPR1142, Montpellier, France; and 5 Department of Microbiology and Immunology, University of Arizona Health Sciences Center, Tucson, Arizona
Requests for reprints: Kuan-Teh Jeang, Building 4, Room 306, 9000 Rockville Pike, Bethesda, MD 20892-0460. Phone: 301-496-6680; Fax: 301-480-3686; E-mail: kj7e{at}nih.gov.
Key Words: HTLV-1 Adult T-cell leukemia miRNA transformation TP53INP1
A role for microRNAs (miRNA) in human T-cell leukemia virus 1 (HTLV-1)–mediated cellular transformation has not been described. Here, we profiled miRNA expression in HTLV-1–transformed human T-cell lines and primary peripheral blood mononuclear cells from adult T-cell leukemia patients. Analyses of 11 different profiles revealed six miRNAs that were consistently up-regulated. Two of the up-regulated miRNAs (miR-93 and miR-130b) target the 3' untranslated region (3'UTR) of the mRNA for a tumor suppressor protein, tumor protein 53–induced nuclear protein 1 (TP53INP1). A low expression level of TP53INP1 protein was found in HTLV-1–transformed cells. Additionally, when antagomirs were used to knock down miR-93 and miR-130b in these cells, the expression of TP53INP1 was increased, suggesting that the latter is regulated inside cells by the former. A role for TP53INP1 in regulating cell growth was established by experiments that showed that enhanced TP53INP1 expression increased apoptosis. Collectively, the findings implicate a miR-93/miR-130b-TP53INP1 axis that affects the proliferation and survival of HTLV-1–infected/transformed cells. [Cancer Res 2008;68(21):8976–85]
This article has been cited by other articles:
![]() |
L. P. Tan, E. Seinen, G. Duns, D. de Jong, O. C. M. Sibon, S. Poppema, B.-J. Kroesen, K. Kok, and A. van den Berg A high throughput experimental approach to identify miRNA targets in human cells Nucleic Acids Res., November 1, 2009; 37(20): e137 - e137. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yao, Y. Zhao, L. P. Smith, C. H. Lawrie, N. J. Saunders, M. Watson, and V. Nair Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines J. Gen. Virol., July 1, 2009; 90(7): 1551 - 1559. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |